id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
508607,7b41a8a9-d683-4cff-89b2-e40cfd8784ff,MM,CAPITOL HILL CONSULTING GROUP,72053,ELI LILLY AND COMPANY,2007,mid_year,PHA,General pharmaceutical issues pertaining to Eli Lilly and Company.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2007-08-01T12:22:34-04:00